Hyrimoz - NDC Database

14 records found

Page:1

61314-454 Jul 01, 2023
Hyrimoz 80 mg/.8ml Subcutaneous Injection, Solution by Sandoz Inc

61314-473 Jul 01, 2023
Hyrimoz 40 mg/.4ml Subcutaneous Injection, Solution by Sandoz Inc

61314-476 Jul 01, 2023
Hyrimoz 20 mg/.2ml Subcutaneous Injection, Solution by Sandoz Inc

61314-509 Jul 01, 2023
Hyrimoz 10 mg/.1ml Subcutaneous Injection, Solution by Sandoz Inc

61314-517 Jul 01, 2023
HyrimozHyrimoz Kit by Sandoz Inc

61314-531 Jul 01, 2023
HyrimozHyrimoz Kit by Sandoz Inc

83457-100 Sep 21, 2023
Hyrimoz 40 mg/.4ml Subcutaneous Injection, Solution by Cordavis Limited

83457-101 Sep 21, 2023
Hyrimoz 40 mg/.4ml Subcutaneous Injection, Solution by Cordavis Limited

83457-102 Sep 21, 2023
Hyrimoz 40 mg/.8ml Subcutaneous Injection, Solution by Cordavis Limited

83457-103 Sep 21, 2023
Hyrimoz 40 mg/.8ml Subcutaneous Injection, Solution by Cordavis Limited

83457-107 Dec 15, 2023
Hyrimoz 80 mg/.8ml Subcutaneous Injection, Solution by Cordavis Limited

83457-108 Dec 15, 2023
Hyrimoz 20 mg/.2ml Subcutaneous Injection, Solution by Cordavis Limited

83457-112 Dec 15, 2023
HyrimozHyrimoz Kit by Cordavis Limited

83457-113 Dec 15, 2023
Hyrimoz 80 mg/.8ml Subcutaneous Injection, Solution by Cordavis Limited

Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.